The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting.
Respir Res
; 24(1): 199, 2023 Aug 11.
Article
in En
| MEDLINE
| ID: mdl-37568199
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bronchiectasis
/
Cystic Fibrosis
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Respir Res
Year:
2023
Document type:
Article
Affiliation country:
Ireland